According to the latest study, inhaled cannabis decreases self-reported migraine severity by 49.6% and headache severity by 47.3%. The study was carried by Carrie Cuttler—Assistant Professor of Psychology from Washington State University—and was published in the Journal of Pain. It is a first to use large data from migraine and headache patients using cannabis in real-time. The past studies have indicated that cannabis was better compared to ibuprofen in lessening headache, but it utilized nabilone—which is a synthetic cannabinoid drug. Cuttler said, “We were encouraged to do this study as a large number of people assert that they use cannabis for migraine and headache, but shockingly few studies had addressed the topic.”
Researchers examined archival statistics from the Strainprint app that permits patients to trace indications before and after using medical cannabis obtained from Canadian distributors. Cuttler along with her colleagues reported no proof that cannabis-induced “overuse headache,” a drawback of more traditional treatments that can make patients’ headaches worse eventually. Nevertheless, they found patients using high doses of cannabis over time, citing they might be developing resistance to the drug. The study stated that there was reduction in headache and men reported 90% while women 89.1%. Researchers said that cannabis concentrates—like cannabis oil—reduced headache severity ratings than cannabis flower.
On a similar note, recently, a study stated that everyday cannabis use reduces chances of using illegal opioids amongst people having chronic pain. For those utilizing illegitimate opioids to deal with their chronic pain, cannabis might be a beneficial—and a less harmful—option, according to research from the BCCSU (BC Centre on Substance Use). Scientists from the BCCSU and UBC (University of British Columbia) found that use of cannabis every day was linked with considerably minor odds of daily prohibited opioid use, indicating people are substituting opioids with cannabis to deal with their pain. The research was published in PLOS Medicine.
Having more than 4 years of experience in the industry, it has been a couple of years for Ramona to be at
Medical Device News. She is responsible for anything that takes place in the Health Department, making her the sole leader of the department. She has also grabbed a couple of certificates to justify her role. Ramona appreciates a cool coffee shop, finds learning incredibly motivating, and is an aspirant urban farmer in her apartment.